Based on our present study, we hypothesise that human lung AAH lesions, the precursors for adenocarcinomas, may respond to chemopreventive interventions targeting the microenvironment with CCR1 inhibitors, NPC2 protein itself or chemicals that up-regulate NPC2 expression. This evidence concerns the gene CCR1 and adenocarcinoma.